Key facts
- This page summarizes Janet Hall's Form 4 filing for Guardion Health Sciences, Inc..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 31 May 2023, 20:11.
Janet Hall - 30 May 2023 Form 4 Insider Report for Guardion Health Sciences, Inc.
- Reporting relationship
- CEO & President
- Issuer ticker
- N/A
- Reported as of
- 30 May 2023
- Net transaction value
- $0
- Reporting owner signature
- /s/ Janet Hall
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Janet Hall filed Form 4 for Guardion Health Sciences, Inc. on 31 May 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GHSI
transaction
Derivative
Stock option (right to buy)
Award
- Transaction value
- $0
- Shares
- +10,000
- Change %
- Price
- $0.000000
- Shares after
- 10,000
- Date
- 30 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $6.01
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock option vests ratably in eight (8) equal installments over a period of two (2) years, with one-eighth (12.5%) of the option vesting each fiscal quarter commencing on September 30, 2023.